These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11780723)

  • 1. Glomerular endothelial cells are maintained by vascular endothelial growth factor in the adult kidney.
    Kitamoto Y; Takeya M; Tokunaga H; Tomita K
    Tohoku J Exp Med; 2001 Sep; 195(1):43-54. PubMed ID: 11780723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [VEGF is an essential molecule for glomerular endothelial cells and its excretion in urine might be a unique marker of glomerular injury].
    Kitamoto Y; Tokunaga H; Miyamoto K; Tomita K
    Rinsho Byori; 2000 Jun; 48(6):485-90. PubMed ID: 10897664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.
    Sugimoto H; Hamano Y; Charytan D; Cosgrove D; Kieran M; Sudhakar A; Kalluri R
    J Biol Chem; 2003 Apr; 278(15):12605-8. PubMed ID: 12538598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
    Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis.
    Horita Y; Miyazaki M; Koji T; Kobayashi N; Shibuya M; Razzaque MS; Cheng M; Ozono Y; Kohno S; Taguchi T
    Nephrol Dial Transplant; 1998 Oct; 13(10):2519-28. PubMed ID: 9794554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice.
    Mattot V; Moons L; Lupu F; Chernavvsky D; Gómez RA; Collen D; Carmeliet P
    J Am Soc Nephrol; 2002 Jun; 13(6):1548-60. PubMed ID: 12039984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation.
    Chakraborty I; Das SK; Dey SK
    J Endocrinol; 1995 Nov; 147(2):339-52. PubMed ID: 7490564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors.
    Feng D; Nagy JA; Brekken RA; Pettersson A; Manseau EJ; Pyne K; Mulligan R; Thorpe PE; Dvorak HF; Dvorak AM
    J Histochem Cytochem; 2000 Apr; 48(4):545-56. PubMed ID: 10727296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
    Millauer B; Shawver LK; Plate KH; Risau W; Ullrich A
    Nature; 1994 Feb; 367(6463):576-9. PubMed ID: 8107827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
    Aiello LP; Pierce EA; Foley ED; Takagi H; Chen H; Riddle L; Ferrara N; King GL; Smith LE
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10457-61. PubMed ID: 7479819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF is an essential molecule for glomerular structuring.
    Kitamoto Y; Tokunaga H; Miyamoto K; Tomita K
    Nephrol Dial Transplant; 2002; 17 Suppl 9():25-7. PubMed ID: 12386279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.
    Binétruy-Tournaire R; Demangel C; Malavaud B; Vassy R; Rouyre S; Kraemer M; Plouët J; Derbin C; Perret G; Mazié JC
    EMBO J; 2000 Apr; 19(7):1525-33. PubMed ID: 10747021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor as a marker of tumor endothelium.
    Brekken RA; Huang X; King SW; Thorpe PE
    Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.
    Kitamoto Y; Tokunaga H; Tomita K
    J Clin Invest; 1997 May; 99(10):2351-7. PubMed ID: 9153276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia.
    Brockelsby J; Hayman R; Ahmed A; Warren A; Johnson I; Baker P
    Lab Invest; 1999 Sep; 79(9):1101-11. PubMed ID: 10496528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.
    Verheul HM; Hoekman K; Jorna AS; Smit EF; Pinedo HM
    Oncologist; 2000; 5 Suppl 1():45-50. PubMed ID: 10804091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.
    Zhu Z; Lu D; Kotanides H; Santiago A; Jimenez X; Simcox T; Hicklin DJ; Bohlen P; Witte L
    Cancer Lett; 1999 Mar; 136(2):203-13. PubMed ID: 10355750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.